{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:13:30Z","timestamp":1790961210548,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/igo\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1184344"],"award-info":[{"award-number":["OPP1184344"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY025350"],"award-info":[{"award-number":["R01 EY025350"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 EY031372"],"award-info":[{"award-number":["K12 EY031372"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progress towards elimination of trachoma as a public health problem has been substantial, but the coronavirus disease 2019 (COVID-19) pandemic has disrupted community-based control efforts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We use a susceptible-infected model to estimate the impact of delayed distribution of azithromycin treatment on the prevalence of active trachoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identify three distinct scenarios for geographic districts depending on whether the basic reproduction number and the treatment-associated reproduction number are above or below a value of 1. We find that when the basic reproduction number is &amp;lt;1, no significant delays in disease control will be caused. However, when the basic reproduction number is &amp;gt;1, significant delays can occur. In most districts, 1\u00a0y of COVID-related delay can be mitigated by a single extra round of mass drug administration. However, supercritical districts require a new paradigm of infection control because the current strategies will not eliminate disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>If the pandemic can motivate judicious, community-specific implementation of control strategies, global elimination of trachoma as a public health problem could be accelerated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/trstmh\/traa170","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T07:27:06Z","timestamp":1610263626000},"page":"222-228","source":"Crossref","is-referenced-by-count":16,"title":["Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem"],"prefix":"10.1093","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5495-4238","authenticated-orcid":false,"given":"Seth","family":"Blumberg","sequence":"first","affiliation":[{"name":"Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Borlase","sequence":"additional","affiliation":[{"name":"University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-5931","authenticated-orcid":false,"given":"Joaquin M","family":"Prada","sequence":"additional","affiliation":[{"name":"Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony W","family":"Solomon","sequence":"additional","affiliation":[{"name":"Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Emerson","sequence":"additional","affiliation":[{"name":"International Trachoma Initiative, Task Force for Global Health, Decatur, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela J","family":"Hooper","sequence":"additional","affiliation":[{"name":"International Trachoma Initiative, Task Force for Global Health, Decatur, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S","family":"Deiner","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Amoah","sequence":"additional","affiliation":[{"name":"Lancaster Medical School, Lancaster University, Bailrigg, Lancaster, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T D\u00e9irdre","family":"Hollingsworth","sequence":"additional","affiliation":[{"name":"University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C","family":"Porco","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-0240","authenticated-orcid":false,"given":"Thomas M","family":"Lietman","sequence":"additional","affiliation":[{"name":"Francis I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA"},{"name":"Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"2021031104192114000_bib1","volume-title":"Validation of elimination of trachoma as a public health problem","author":"World Health Organization","year":"2020]"},{"issue":"4","key":"2021031104192114000_bib2","first-page":"477","article-title":"A simple system for the assessment of trachoma and its complications","volume":"65","author":"Thylefors","year":"1987","journal-title":"Bull World Health Org"},{"key":"2021031104192114000_bib3","author":"World Health Organization"},{"issue":"7","key":"2021031104192114000_bib4","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1101\/gr.212647.116","article-title":"Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion","volume":"27","author":"Hadfield","year":"2017","journal-title":"Genome Res"},{"issue":"9379","key":"2021031104192114000_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0140-6736(03)13914-1","article-title":"Trachoma","volume":"362","author":"Mabey","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"2021031104192114000_bib6","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1473-3099(07)70137-8","article-title":"Trachoma: transmission, infection, and control","volume":"7","author":"Gambhir","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"2021031104192114000_bib7","first-page":"CD001860","article-title":"Antibiotics for trachoma","volume":"9","author":"Evans","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2021031104192114000_bib8","first-page":"CD004008","article-title":"Interventions for trachoma trichiasis","author":"Burton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021031104192114000_bib9","author":"WHO validates Myanmar for eliminating trachoma as a public health problem"},{"key":"2021031104192114000_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198545996.001.0001","volume-title":"Infectious diseases of humans: dynamics and control","author":"Anderson","year":"1991"},{"key":"2021031104192114000_bib11","author":"Borlase"},{"issue":"9379","key":"2021031104192114000_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0140-6736(03)13909-8","article-title":"Strategies for control of trachoma: observational study with quantitative PCR","volume":"362","author":"Solomon","year":"2003","journal-title":"Lancet"},{"issue":"10","key":"2021031104192114000_bib13","doi-asserted-by":"crossref","first-page":"e0006478","DOI":"10.1371\/journal.pntd.0006478","article-title":"Identifying a sufficient core group for trachoma transmission","volume":"12","author":"Lietman","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2021031104192114000_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/8451","article-title":"Global elimination of trachoma: how frequently should we administer mass chemotherapy","volume":"5","author":"Lietman","year":"1999","journal-title":"Nat Med"},{"issue":"12","key":"2021031104192114000_bib15","doi-asserted-by":"crossref","first-page":"e341","DOI":"10.1371\/journal.pntd.0000341","article-title":"The natural history of trachoma infection and disease in a Gambian cohort with frequent follow-up","volume":"2","author":"Grassly","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"2021031104192114000_bib16","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1371\/journal.pntd.0000458","article-title":"When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries","volume":"3","author":"Ray","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"2021031104192114000_bib17","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1086\/374743","article-title":"Does the diagnosis of trachoma adequately identify ocular chlamydial infection in trachoma-endemic areas?","volume":"187","author":"Bird","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"2021031104192114000_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4269\/ajtmh.2010.09-0315","article-title":"Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma","volume":"82","author":"Keenan","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"2021031104192114000_bib19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/aje\/kws345","article-title":"Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma","volume":"177","author":"Koukounari","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"1","key":"2021031104192114000_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s13071-015-1115-8","article-title":"Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection","volume":"8","author":"Liu","year":"2015","journal-title":"Parasites Vectors"},{"issue":"1","key":"2021031104192114000_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S1473-3099(05)70304-2","article-title":"Clinical examination versus Chlamydia trachomatis assays to guide antibiotic use in trachoma control programmes","volume":"6","author":"Solomon","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2021031104192114000_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(05)70116-X","article-title":"Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?","volume":"5","author":"Wright","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"2021031104192114000_bib23","first-page":"3061","article-title":"Does the clinical exam adequately identify ocular chlamydial infection in trachoma?","volume":"43","author":"Bird","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2021031104192114000_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archophthalmol.2011.46","article-title":"Slow resolution of clinically active trachoma following successful mass antibiotic treatments","volume":"129","author":"Keenan","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"2021031104192114000_bib25","doi-asserted-by":"crossref","first-page":"e2115","DOI":"10.1371\/journal.pntd.0002115","article-title":"Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia","volume":"7","author":"Harding-Esch","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"2021031104192114000_bib26","doi-asserted-by":"crossref","first-page":"e0003610","DOI":"10.1371\/journal.pntd.0003610","article-title":"Mass drug administration for trachoma: how long is not long enough?","volume":"9","author":"Jimenez","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2021031104192114000_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09286586.2017.1293693","article-title":"Evaluation of a single dose of azithromycin for trachoma in low-prevalence communities","volume":"26","author":"Wilson","year":"2019","journal-title":"Ophthalmic Epidemiol"},{"issue":"Suppl 5","key":"2021031104192114000_bib28","doi-asserted-by":"crossref","first-page":"S519","DOI":"10.1093\/infdis\/jiz691","article-title":"Trachoma prevalence after discontinuation of mass azithromycin distribution","volume":"221","author":"Godwin","year":"2020","journal-title":"J Infect Dis"},{"issue":"2","key":"2021031104192114000_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.epidem.2011.03.004","article-title":"The epidemiological dynamics of infectious trachoma may facilitate elimination","volume":"3","author":"Lietman","year":"2011","journal-title":"Epidemics"},{"key":"2021031104192114000_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa933","article-title":"Predicted impact of COVID-19 on neglected tropical disease programs and the opportunity for innovation","author":"Toor","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021031104192114000_bib31","first-page":"241","article-title":"Mass drug administration: the importance of synchrony","volume":"34","author":"Gao","year":"2017","journal-title":"Math Med Biol"},{"issue":"6","key":"2021031104192114000_bib32","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.292.6.721","article-title":"Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments","volume":"292","author":"Melese","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"2021031104192114000_bib33","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","article-title":"Reduction and return of infectious trachoma in severely affected communities in Ethiopia","volume":"3","author":"Lakew","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 4","key":"2021031104192114000_bib34","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1093\/cid\/ciy004","article-title":"Models of trachoma transmission and their policy implications: from control to elimination","volume":"66","author":"Lietman","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"9669","key":"2021031104192114000_bib35","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(09)60323-8","article-title":"Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial","volume":"373","author":"House","year":"2009","journal-title":"Lancet"},{"key":"2021031104192114000_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12916-016-0614-6","article-title":"Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: a modelling study","volume":"14","author":"Pinsent","year":"2016","journal-title":"BMC Med"},{"issue":"9179","key":"2021031104192114000_bib37","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(98)12387-5","article-title":"Azithromycin in control of trachoma","volume":"354","author":"Schachter","year":"1999","journal-title":"Lancet"},{"issue":"7","key":"2021031104192114000_bib38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.299.7.778","article-title":"Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma","volume":"299","author":"Melese","year":"2008","journal-title":"JAMA"},{"issue":"9811","key":"2021031104192114000_bib39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(11)61515-8","article-title":"Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial","volume":"379","author":"Gebre","year":"2012","journal-title":"Lancet"},{"issue":"6","key":"2021031104192114000_bib40","first-page":"743","article-title":"A cluster-randomized trial to assess the efficacy of targeting trachoma treatment to children","volume":"64","author":"Amza","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2021031104192114000_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.292.6.721","article-title":"Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments","volume":"292","author":"Melese","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"2021031104192114000_bib42","doi-asserted-by":"crossref","first-page":"e0008033","DOI":"10.1371\/journal.pntd.0008033","article-title":"Modelling for policy: the five principles of the Neglected Tropical Diseases Modelling Consortium","volume":"14","author":"Behrend","year":"2020","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Transactions of The Royal Society of Tropical Medicine and Hygiene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/115\/3\/222\/36508504\/traa170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/trstmh\/article-pdf\/115\/3\/222\/36508504\/traa170.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:01:40Z","timestamp":1724284900000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/trstmh\/article\/115\/3\/222\/6101238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,1,15]]},"published-print":{"date-parts":[[2021,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/trstmh\/traa170","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.26.20219691","asserted-by":"object"}]},"ISSN":["0035-9203","1878-3503"],"issn-type":[{"value":"0035-9203","type":"print"},{"value":"1878-3503","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3]]},"published":{"date-parts":[[2021,1,15]]}}}